These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 21133623)
1. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects. Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623 [TBL] [Abstract][Full Text] [Related]
2. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504 [TBL] [Abstract][Full Text] [Related]
3. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma. Chiu MM; Ko YJ; Tsou AP; Chau GY; Chau YP Histol Histopathol; 2009 Oct; 24(10):1223-32. PubMed ID: 19688691 [TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998 [TBL] [Abstract][Full Text] [Related]
5. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors]. Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302 [TBL] [Abstract][Full Text] [Related]
7. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035 [TBL] [Abstract][Full Text] [Related]
8. The NQO1 C609T polymorphism and hepatocellular carcinoma risk. Fan Y; Hu D; Feng B; Wang W Tumour Biol; 2014 Aug; 35(8):7343-50. PubMed ID: 24532470 [TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953 [TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958 [TBL] [Abstract][Full Text] [Related]
12. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population. Bayram S Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463 [TBL] [Abstract][Full Text] [Related]
13. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer]. Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229 [TBL] [Abstract][Full Text] [Related]
14. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis. Gong M; Yi Q; Wang W Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485 [TBL] [Abstract][Full Text] [Related]
15. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737 [TBL] [Abstract][Full Text] [Related]
16. No association of the exonuclease 1 T439M polymorphism and risk of hepatocellular carcinoma development in the Turkish population: a case-control study. Bayram S; Akkiz H; Bekar A; Akgöllü E; Yıldırım S Asian Pac J Cancer Prev; 2011; 12(9):2455-60. PubMed ID: 22296401 [TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274 [TBL] [Abstract][Full Text] [Related]
18. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891 [TBL] [Abstract][Full Text] [Related]
19. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population. Zhao H; Zou LW; Zheng SS; Geng XP Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831 [TBL] [Abstract][Full Text] [Related]
20. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning]. Chen Y; Li GL; Ji ZY; Xu JN; Wu CL Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]